CCR8 and cancer: In the following study involving a murine liver cancer model, IPG0521 with murine IgG2a Fc was constructed, named IPG0521m, which potently blocked the chemotaxis of CCR8+ Treg derived from murine cancer models (Fig. S5A-B).